Infosys rallies 9% post Q2 earnings; stock hits new high
.jpg)
Infosys is trading higher by nearly 2% at Rs 3,952, extending its Friday’s nearly 7% rally, after the company reported a better-than-expected consolidated net profit at Rs 3,096 crore for the second quarter ended September 30, 2014 (Q2) besides declaring 1:1 bonus.
The stock opened at Rs 3,898 and hit new high of Rs 3,959 on National Stock Exchange (NSE). A combined 1.92 million shares changed hands on the counter so far on NSE and BSE.
In his first investor interaction, Infosys Chief Executive Officer & Managing Director, Dr. Vishal Sikka re-affirmed revenue growth should return to the industry levels by FY17.
The aim would be to become the next generation services company with 15-18% USD revenue growth and 25-28% EBIT margins longer term, he had said.
Despite the run up already seen in the stock, analysts remain bullish on the counter. Bhuvnesh Singh and Hitesh Da, analysts at Barclays maintain overweight rating on the stock and have revised price target to Rs 4,650.
“While details of the new strategy should emerge over the next few months, we believe that the new CEO's plan to embrace newer technologies such as automation and AI to drive growth is a step in the right direction,” analysts said in research report.
Other Latest News
.webp)
AAP supremo Arvind Kejriwal on Thursday intensified his criticism of the BJP-led central government, accusing it of failing to ensure law and order in Delhi.
Addressing a press conference at party office, Kejriwal said, "There is an atmosphere of fear and insecurity everywhere in Delhi. Women feel unsafe stepping out after 7 pm and parents worry about their daughters going outside."
.webp)
The High Court on Thursday refused to ban ISKCON's activities in Bangladesh, a local newspaper reported days after a lawyer was killed in a clash between security personnel and supporters of a Hindu leader arrested on sedition charges.
The lawyer had sought a ban from the high court on the International Society for Krishna Consciousness (ISKCON) after placing some newspaper reports related to the organisation on Wednesday.
.webp)
The Manipur government on Thursday announced that classes in schools and colleges in Imphal Valley districts and Jiribam would resume from November 28 after a hiatus of 13 days.
Educational institutes in these districts have remained closed since November 16 after the dead bodies of three women and three children in Jiribam were recovered from the Jiri and Barak rivers in Manipur and Assam respectively.
.webp)
Eknath Shinde, who served as chief minister in the outgoing Maharashtra government, is unlikely to accept the post of deputy CM in the new dispensation, his close aide Sanjay Shirsat said on Thursday.
Shirsat, an MLA and spokesperson of the Shiv Sena, however, said Shinde would be a part of the cabinet.
.webp)
Dr. Reddy’s announced the launch of Toripalimab in India on Thursday, for patients diagnosed with nasopharyngeal carcinoma (NPC), a rare form of head and neck cancer.
Toripalimab, a New Biological Entity (NBE), is the only immuno-oncology drug approved by regulatory authorities like the USFDA, EMA, and MHRA for treating adults with recurrent or metastatic nasopharyngeal carcinoma (RM-NPC). It is globally recognised for its efficacy in this indication, the Hyderabad-based company said in a statement.
.webp)
.webp)
.webp)
.webp)
.webp)
